RNATICS

Private

GermanyHealthcare & Life Scienceshttps://rnatics.com/

Last Round

Grant

Feb 20, 2026

Total Funding Raised

$11.1M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

RNATICS is a drug discovery company that develops RNA-based therapeutic methods intended for the treatment of severe diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

RNA therapeuticsantisense oligonucleotideASOmacrophage targetingidiopathic pulmonary fibrosisIPFRNA drug deliverydrug delivery platformmicroRNA inhibitormiRNA inhibitorfibrotic diseaseslung disease treatmentinflammatory diseasesclinical stage biotechbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RNATICS Comps

Public and private peers based on sector, stage, and business model.

RNATICS comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RNATICS Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Feb 20, 2026
Accelerator	Jun 26, 2024
Grant	Jan 13, 2022
Spinoff	Jan 1, 2021

View all Funding Rounds

RNATICS Investors

Notable investors and investment history

RNATICS investors
Investor	Rounds
Technical University of Munich	Spinoff
Munich Accelerator Life Sciences & Medicine	Accelerator
BioM AG Munich BioTech Development	Accelerator
Federal Ministry of Research, Technology and Space	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 15, 2026
Monthly visitors increased 276% MoM.
Feb 20, 2026
$3.18M grant from the Federal Ministry of Research, Technology and Space.

View all signals

RNATICS Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RNATICS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RNATICS's valuation, stock price, and market status.

Firmographic Details

HeadquartersGermany

Employee Range5

Year Founded2021

Last FundingFeb 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.